Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2017, Volume 2017, Issue 10, p. CD006491
Background Mefloquine is one of four antimalarial agents commonly recommended for preventing malaria in travellers to malaria-endemic areas. Despite its high...
CHLOROQUINE PLUS PROGUANIL | PEACE-CORPS VOLUNTEERS | MEDICINE, GENERAL & INTERNAL | SULFADOXINE-PYRIMETHAMINE | ATOVAQUONE-PROGUANIL | DOUBLE-BLIND | UNITED-STATES TROOPS | SHORT-TERM TRAVELERS | PLASMODIUM-FALCIPARUM MALARIA | ADVERSE EVENTS | ANTIMALARIAL CHEMOPROPHYLAXIS | Atovaquone - adverse effects | Doxycycline - adverse effects | Antimalarials - adverse effects | Malaria, Falciparum - prevention & control | Atovaquone - therapeutic use | Doxycycline - therapeutic use | Humans | Chloroquine - therapeutic use | Antimalarials - therapeutic use | Chloroquine - adverse effects | Proguanil - adverse effects | Mefloquine - adverse effects | Randomized Controlled Trials as Topic | Proguanil - therapeutic use | Travel-Related Illness | Drug Therapy, Combination - methods | Mefloquine - therapeutic use | Primaquine - therapeutic use | Adult | Primaquine - adverse effects | Child | Drug Combinations | Drug Resistance
CHLOROQUINE PLUS PROGUANIL | PEACE-CORPS VOLUNTEERS | MEDICINE, GENERAL & INTERNAL | SULFADOXINE-PYRIMETHAMINE | ATOVAQUONE-PROGUANIL | DOUBLE-BLIND | UNITED-STATES TROOPS | SHORT-TERM TRAVELERS | PLASMODIUM-FALCIPARUM MALARIA | ADVERSE EVENTS | ANTIMALARIAL CHEMOPROPHYLAXIS | Atovaquone - adverse effects | Doxycycline - adverse effects | Antimalarials - adverse effects | Malaria, Falciparum - prevention & control | Atovaquone - therapeutic use | Doxycycline - therapeutic use | Humans | Chloroquine - therapeutic use | Antimalarials - therapeutic use | Chloroquine - adverse effects | Proguanil - adverse effects | Mefloquine - adverse effects | Randomized Controlled Trials as Topic | Proguanil - therapeutic use | Travel-Related Illness | Drug Therapy, Combination - methods | Mefloquine - therapeutic use | Primaquine - therapeutic use | Adult | Primaquine - adverse effects | Child | Drug Combinations | Drug Resistance
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1465-1858, 11/2018, Volume 2018, Issue 11, p. CD010578
Supplementary feeding may help food insecure and vulnerable people by optimising the nutritional value and adequacy of the diet, improving quality of life and...
Dietary Proteins - administration & dosage | Age Factors | Malnutrition - diet therapy | Humans | Middle Aged | Stillbirth | Child, Preschool | Nutritional Physiological Phenomena | Infant | Male | Vulnerable Populations | Alzheimer Disease - diet therapy | Adult | Female | HIV Infections - mortality | Child Development | Child | Food Supply | Pregnancy Complications - diet therapy | HIV Infections - diet therapy | Energy Intake | Malnutrition - mortality | Pregnancy | Micronutrients | Tuberculosis, Pulmonary - mortality | Adolescent | Systematic Reviews as Topic | Aged | Tuberculosis, Pulmonary - diet therapy
Dietary Proteins - administration & dosage | Age Factors | Malnutrition - diet therapy | Humans | Middle Aged | Stillbirth | Child, Preschool | Nutritional Physiological Phenomena | Infant | Male | Vulnerable Populations | Alzheimer Disease - diet therapy | Adult | Female | HIV Infections - mortality | Child Development | Child | Food Supply | Pregnancy Complications - diet therapy | HIV Infections - diet therapy | Energy Intake | Malnutrition - mortality | Pregnancy | Micronutrients | Tuberculosis, Pulmonary - mortality | Adolescent | Systematic Reviews as Topic | Aged | Tuberculosis, Pulmonary - diet therapy
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 07/2015, Volume 2015, Issue 7, p. CD000371
Background The World Health Organization (WHO) recommends treating all school children at regular intervals with deworming drugs in areas where helminth...
Humans | MULTI-MICRONUTRIENT SUPPLEMENTATION | RANDOMIZED CONTROLLED-TRIAL | Growth [drug effects] | IRON SUPPLEMENTATION | Anthelmintics [pharmacology; therapeutic use] | TRICHURIS-TRICHIURA INFECTION | MEDICINE, GENERAL & INTERNAL | HELMINTH INFECTIONS | Nutritional Status [drug effects] | Helminthiasis [complications; drug therapy] | ASCARIS-LUMBRICOIDES INFECTIONS | Child | MALNOURISHED PRESCHOOL-CHILDREN | Soil [parasitology] | ANTHELMINTIC TREATMENT | Preschool | Cognition [drug effects] | Randomized Controlled Trials as Topic | Child Development [drug effects] | VITAMIN-A STATUS | Intestinal Diseases, Parasitic [complications; drug therapy] | Weight Gain [drug effects] | Adolescent | DOUBLE-BLIND | Hemoglobin A - drug effects | Soil - parasitology | Intestinal Diseases, Parasitic - drug therapy | Child, Preschool | Cognition - drug effects | Endemic Diseases | Growth - drug effects | Anthelmintics - pharmacology | Nutritional Status - drug effects | Helminthiasis - complications | Weight Gain - drug effects | Child Development - drug effects | Helminthiasis - drug therapy | Anthelmintics - therapeutic use | Intestinal Diseases, Parasitic - complications
Humans | MULTI-MICRONUTRIENT SUPPLEMENTATION | RANDOMIZED CONTROLLED-TRIAL | Growth [drug effects] | IRON SUPPLEMENTATION | Anthelmintics [pharmacology; therapeutic use] | TRICHURIS-TRICHIURA INFECTION | MEDICINE, GENERAL & INTERNAL | HELMINTH INFECTIONS | Nutritional Status [drug effects] | Helminthiasis [complications; drug therapy] | ASCARIS-LUMBRICOIDES INFECTIONS | Child | MALNOURISHED PRESCHOOL-CHILDREN | Soil [parasitology] | ANTHELMINTIC TREATMENT | Preschool | Cognition [drug effects] | Randomized Controlled Trials as Topic | Child Development [drug effects] | VITAMIN-A STATUS | Intestinal Diseases, Parasitic [complications; drug therapy] | Weight Gain [drug effects] | Adolescent | DOUBLE-BLIND | Hemoglobin A - drug effects | Soil - parasitology | Intestinal Diseases, Parasitic - drug therapy | Child, Preschool | Cognition - drug effects | Endemic Diseases | Growth - drug effects | Anthelmintics - pharmacology | Nutritional Status - drug effects | Helminthiasis - complications | Weight Gain - drug effects | Child Development - drug effects | Helminthiasis - drug therapy | Anthelmintics - therapeutic use | Intestinal Diseases, Parasitic - complications
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 7, Issue 7, p. CD000371
Background The World Health Organization (WHO) recommends treating all school children at regular intervals with deworming drugs in areas where helminth...
Humans | ANTHELMINTIC TREATMENT | MULTI-MICRONUTRIENT SUPPLEMENTATION | Child, Preschool | Cognition [drug effects] | RANDOMIZED CONTROLLED-TRIAL | Growth [drug effects] | IRON SUPPLEMENTATION | Anthelmintics [pharmacology; therapeutic use] | Randomized Controlled Trials as Topic | TRICHURIS-TRICHIURA INFECTION | MEDICINE, GENERAL & INTERNAL | Child Development [drug effects] | VITAMIN-A STATUS | Intestinal Diseases, Parasitic [complications; drug therapy] | Weight Gain [drug effects] | HELMINTH INFECTIONS | Nutritional Status [drug effects] | Adolescent | DOUBLE-BLIND | Helminthiasis [complications; drug therapy] | ASCARIS-LUMBRICOIDES INFECTIONS | Child | MALNOURISHED PRESCHOOL-CHILDREN | Soil - parasitology | Intestinal Diseases, Parasitic - drug therapy | Cognition - drug effects | Growth - drug effects | Anthelmintics - pharmacology | Nutritional Status - drug effects | Helminthiasis - complications | Weight Gain - drug effects | Child Development - drug effects | Helminthiasis - drug therapy | Anthelmintics - therapeutic use | Intestinal Diseases, Parasitic - complications
Humans | ANTHELMINTIC TREATMENT | MULTI-MICRONUTRIENT SUPPLEMENTATION | Child, Preschool | Cognition [drug effects] | RANDOMIZED CONTROLLED-TRIAL | Growth [drug effects] | IRON SUPPLEMENTATION | Anthelmintics [pharmacology; therapeutic use] | Randomized Controlled Trials as Topic | TRICHURIS-TRICHIURA INFECTION | MEDICINE, GENERAL & INTERNAL | Child Development [drug effects] | VITAMIN-A STATUS | Intestinal Diseases, Parasitic [complications; drug therapy] | Weight Gain [drug effects] | HELMINTH INFECTIONS | Nutritional Status [drug effects] | Adolescent | DOUBLE-BLIND | Helminthiasis [complications; drug therapy] | ASCARIS-LUMBRICOIDES INFECTIONS | Child | MALNOURISHED PRESCHOOL-CHILDREN | Soil - parasitology | Intestinal Diseases, Parasitic - drug therapy | Cognition - drug effects | Growth - drug effects | Anthelmintics - pharmacology | Nutritional Status - drug effects | Helminthiasis - complications | Weight Gain - drug effects | Child Development - drug effects | Helminthiasis - drug therapy | Anthelmintics - therapeutic use | Intestinal Diseases, Parasitic - complications
Journal Article
5.
Full Text
Deaths and parasuicides associated with mefloquine chemoprophylaxis: A systematic review
Travel Medicine and Infectious Disease, ISSN 1477-8939, 11/2017, Volume 20, pp. 5 - 14
Mefloquine is recommended in international health guidelines for preventing malaria in travellers. Reports of psychosis and suicide are often alluded to but...
Chemoprophylaxis | Mefloquine | Malaria | Side-effects | DEPRESSION | INFECTIOUS DISEASES | RISK | TOXICITY | MADNESS | ADVERSE DRUG-REACTIONS | MALARIA CHEMOPROPHYLAXIS | PROPHYLAXIS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PSYCHOSIS | SUICIDE | EXPOSURE | Drugs | Vector-borne diseases | Protocols | Human diseases | Mental disorders | Prophylaxis | Systematic review | Identification | Suicide | Data bases | Case studies | Studies | Psychosis | Infectious diseases | Womens health | Suicides & suicide attempts | Fatalities | Drug therapy | Drug dosages | Public health
Chemoprophylaxis | Mefloquine | Malaria | Side-effects | DEPRESSION | INFECTIOUS DISEASES | RISK | TOXICITY | MADNESS | ADVERSE DRUG-REACTIONS | MALARIA CHEMOPROPHYLAXIS | PROPHYLAXIS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PSYCHOSIS | SUICIDE | EXPOSURE | Drugs | Vector-borne diseases | Protocols | Human diseases | Mental disorders | Prophylaxis | Systematic review | Identification | Suicide | Data bases | Case studies | Studies | Psychosis | Infectious diseases | Womens health | Suicides & suicide attempts | Fatalities | Drug therapy | Drug dosages | Public health
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2014, Volume 1, Issue 1, p. CD004396
Background Caring for someone with dementia can be emotionally and physically demanding. Respite care is any intervention designed to give rest or relief to...
Dementia [nursing; psychology] | Stress, Psychological [therapy] | Humans | ALZHEIMERS-DISEASE | BEHAVIOR | RANDOMIZED-TRIAL | FAMILY CAREGIVERS | PREVALENCE | Randomized Controlled Trials as Topic | Caregivers [psychology] | SUPPORT | MEDICINE, GENERAL & INTERNAL | REDUCTION | COMMUNITY | Aged | SERVICE | STRESS | Respite Care [psychology] | Therapeutic Touch | Stress, Psychological - therapy | Respite Care - psychology | Dementia - nursing | Dementia - psychology | Caregivers - psychology
Dementia [nursing; psychology] | Stress, Psychological [therapy] | Humans | ALZHEIMERS-DISEASE | BEHAVIOR | RANDOMIZED-TRIAL | FAMILY CAREGIVERS | PREVALENCE | Randomized Controlled Trials as Topic | Caregivers [psychology] | SUPPORT | MEDICINE, GENERAL & INTERNAL | REDUCTION | COMMUNITY | Aged | SERVICE | STRESS | Respite Care [psychology] | Therapeutic Touch | Stress, Psychological - therapy | Respite Care - psychology | Dementia - nursing | Dementia - psychology | Caregivers - psychology
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1465-1858, 09/2019
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 01/2018, Volume 2018, Issue 1, p. CD000209
Background Antipsychotic (neuroleptic) medication is used extensively to treat people with chronic mental illnesses. Its use, however, is associated with...
Psychotic Disorders [drug therapy] | Vitamins [therapeutic use] | RANDOMIZED CONTROLLED-TRIALS | PLACEBO | EFFICACY | Humans | STATISTICS NOTES | METAANALYSES | Antipsychotic Agents [adverse effects] | ALPHA-TOCOPHEROL | DISCONTINUATION | Randomized Controlled Trials as Topic | INTERRATER RELIABILITY ISSUES | MEDICINE, GENERAL & INTERNAL | MULTICENTER TRIALS | Schizophrenia [drug therapy] | Vitamin E [therapeutic use] | Dyskinesia, Drug-Induced [drug therapy; etiology] | RATING-SCALE | Dyskinesia, Drug-Induced - etiology | Antipsychotic Agents - adverse effects | Vitamin E - adverse effects | Patient Acceptance of Health Care - statistics & numerical data | Vitamins - therapeutic use | Disease Progression | Vitamins - adverse effects | Dyskinesia, Drug-Induced - drug therapy | Vitamin E - therapeutic use | Adult | Psychotic Disorders - drug therapy | Schizophrenia - drug therapy
Psychotic Disorders [drug therapy] | Vitamins [therapeutic use] | RANDOMIZED CONTROLLED-TRIALS | PLACEBO | EFFICACY | Humans | STATISTICS NOTES | METAANALYSES | Antipsychotic Agents [adverse effects] | ALPHA-TOCOPHEROL | DISCONTINUATION | Randomized Controlled Trials as Topic | INTERRATER RELIABILITY ISSUES | MEDICINE, GENERAL & INTERNAL | MULTICENTER TRIALS | Schizophrenia [drug therapy] | Vitamin E [therapeutic use] | Dyskinesia, Drug-Induced [drug therapy; etiology] | RATING-SCALE | Dyskinesia, Drug-Induced - etiology | Antipsychotic Agents - adverse effects | Vitamin E - adverse effects | Patient Acceptance of Health Care - statistics & numerical data | Vitamins - therapeutic use | Disease Progression | Vitamins - adverse effects | Dyskinesia, Drug-Induced - drug therapy | Vitamin E - therapeutic use | Adult | Psychotic Disorders - drug therapy | Schizophrenia - drug therapy
Journal Article